Case
Published · Updated · 2 min read
Rhabdomyolysis during piperacillin/tazobactam therapy: a case report
What it means for practice
The authors emphasize monitoring muscle enzyme levels during piperacillin/tazobactam therapy and promptly recognizing rhabdomyolysis. A single case does not establish the frequency of this complication.
Summary
Case description
The report describes rhabdomyolysis developing in a patient after administration of the antibiotic combination piperacillin/tazobactam. According to the supplied abstract, findings included elevated creatine kinase levels and myoglobinuria. The authors attribute the development of rhabdomyolysis to this combination.
Treatment and outcome
The patient received intravenous fluids and diuretics and subsequently recovered. The abstract does not specify whether the antibiotic was discontinued, when improvement began, or how laboratory findings changed. The contribution of individual treatment measures to recovery therefore cannot be assessed.
Clinical relevance and data limitations
The authors emphasize monitoring muscle enzyme levels during treatment and promptly recognizing and managing this adverse reaction to prevent complications. The supplied abstract does not report the patient’s age, the indication for antibiotic therapy, doses, treatment duration, or numerical creatine kinase values. It also provides no information on concomitant medications, alternative causes of rhabdomyolysis, or formal causality assessment. The report describes a possible association but cannot establish the frequency of the reaction.
Case analysis
- Likely mechanism
- The supplied abstract does not describe the mechanism of rhabdomyolysis. A specific mechanism of the reaction to piperacillin/tazobactam cannot be established from these data.
- Causality assessment
- The authors attribute rhabdomyolysis to piperacillin/tazobactam but report no formal causality assessment. Editorial WHO-UMC assessment: conditional/unclassified; additional information on the time course, drug withdrawal, and alternative causes is required for assessment.
- Take-home lesson
- Drug-associated rhabdomyolysis should be considered when elevated creatine kinase and myoglobinuria occur during piperacillin/tazobactam therapy. The authors emphasize monitoring muscle enzymes and promptly recognizing the reaction.
Source
-
Rhabdomyolysis associated with piperacillin/tazobactam therapy: a case report.
Reviewed by: DrugCard editorial team ·
This article does not replace clinical judgement. Disclaimer
